The drugs most commonly used to induce labor fall into two categories: synthetic oxytocin, often known by the brand name Pitocin, and prostaglandins such as misoprostol and dinoprostone. Which one you receive depends largely on how ready your cervix is for labor. If the cervix is already soft and partially open, oxytocin delivered through an IV can get contractions going directly. If the cervix is still firm and closed, a prostaglandin is typically used first to ripen it, sometimes followed by oxytocin later. A few other agents play smaller or more specialized roles, but oxytocin and prostaglandins account for the vast majority of pharmacological inductions worldwide.
Oxytocin
Oxytocin is a hormone your body produces naturally during labor. The synthetic version, given through an IV drip, mimics what your body already does: it binds to receptors on the muscle cells of the uterus and triggers contractions. By term, high estrogen levels have made those receptors especially sensitive, so even small amounts of the drug can produce a strong response.1PubMed. The physiology and pharmacology of oxytocin in labor and in the peripartum period The dose is started low and increased at regular intervals until contractions settle into a reliable pattern.
Clinical guidelines recommend oxytocin for induction when the cervix is already favorable, generally defined as a Bishop score of 7 or higher. It works best when paired with amniotomy, the deliberate breaking of the water bag, which adds mechanical pressure from the baby’s head against the cervix.2Journal of Obstetrics and Gynaecology Canada. Guidelines for Cervical Ripening and Induction of Labour – Section: RECOMMENDATIONS When the cervix is not yet ready, starting oxytocin alone tends to produce painful but unproductive contractions, which is why cervical ripening with a prostaglandin or a mechanical device usually comes first.
One side effect worth knowing about is water intoxication. Oxytocin has a chemical structure similar to antidiuretic hormone, so at high doses and with large volumes of low-electrolyte IV fluids, it can cause the body to retain water and dilute blood sodium to dangerous levels. This is uncommon in modern practice because providers use lower doses and electrolyte-containing fluids, but it was a recognized hazard historically when large oxytocin doses were standard for mid-trimester procedures.3PubMed. Water intoxication after oxytocin-induced midtrimester abortion
Prostaglandins for Cervical Ripening
When the cervix is not ready for labor, prostaglandins serve double duty: they soften and thin the cervix while also stimulating uterine contractions. Two prostaglandin drugs dominate this space, and they differ more than their similar-sounding names suggest.
Dinoprostone is a synthetic form of prostaglandin E2 (PGE2). It comes as a vaginal insert or a gel placed directly against the cervix. Its ripening effect works partly by triggering inflammatory signals that remodel the tough collagen network of the cervix, loosening and softening it.4PubMed. The role of prostaglandins E1 and E2, dinoprostone, and misoprostol in cervical ripening and the induction of labor: a mechanistic approach – Section: RESULTS The vaginal insert form has the advantage of being removable if contractions become too frequent. Dinoprostone is FDA-approved specifically for cervical ripening, which gives it a clearer regulatory footprint than its competitor.
Misoprostol is a synthetic prostaglandin E1 (PGE1). It was originally developed and marketed for preventing stomach ulcers in people taking anti-inflammatory drugs. Its use in labor induction is off-label, meaning the FDA has not formally approved it for this purpose, even though professional obstetric organizations endorse it based on decades of evidence.5PubMed. Induction of labor: the misoprostol controversy Misoprostol has practical advantages that make it widely used anyway: it is cheap, shelf-stable at room temperature, and can be given by mouth rather than requiring refrigerated inserts or gels.
Misoprostol by Mouth Versus by Vagina
How misoprostol is given matters, and this is an area where the evidence has real clinical stakes. The drug can be placed vaginally, swallowed as a tablet, or dissolved under the tongue. Vaginal and oral routes are the most studied, and their trade-offs are not identical.
A randomized trial comparing 25-microgram vaginal misoprostol with 100-microgram oral misoprostol found that both routes led to vaginal delivery within 24 hours at similar rates, around 77 to 78 percent. But vaginal misoprostol led to fewer women needing oxytocin augmentation before delivery, roughly 69 percent compared with 78 percent for oral. Interestingly, tachysystole with concerning fetal heart rate changes was actually less common with the vaginal route in this trial.6PubMed. Vaginal Compared With Oral Misoprostol Induction at Term: A Cluster Randomized Controlled Trial – Section: RESULTS
A separate study comparing 25-microgram vaginal with 50-microgram oral misoprostol found a more dramatic difference: cesarean delivery rates were about 21 percent with the vaginal route and 32 percent with oral. Among first-time mothers, the gap widened further. Time from induction to vaginal delivery was also shorter with vaginal misoprostol in that study.7PubMed Central. Oral or Vaginal Misoprostol for Labor Induction and Cesarean Delivery Risk – Section: Results These differences may partly reflect the higher oral dose used, since dosing is not standardized across studies. What is clear is that the route and dose pairing you receive can meaningfully affect how your induction unfolds.
The Misoprostol Controversy
Misoprostol’s off-label status has generated more debate than almost any other drug in obstetrics. In 2000, its manufacturer issued a warning against using misoprostol in pregnancy, citing its ability to cause abortion and reports of maternal and fetal deaths during labor induction.5PubMed. Induction of labor: the misoprostol controversy That warning alarmed patients and some providers, but major obstetric organizations continued to endorse the drug’s use, pointing to a large body of trial evidence supporting its safety when dosed appropriately. By the spring of 2002, some regulatory language had shifted, though the drug’s use in pregnancy remained technically off-label.8Obstetrical & Gynecological Survey. Misoprostol: A Quarter Century of Use, Abuse, and Creative Misuse
If your provider recommends misoprostol and the off-label label concerns you, it helps to know that “off-label” does not mean unsupported or experimental. It means the manufacturer never pursued FDA approval for that specific use, often for commercial reasons. The evidence base for misoprostol in labor induction is now enormous, and the drug appears in guidelines from obstetric societies around the world.
Combining Drugs with Mechanical Methods
A Foley catheter balloon inserted through the cervix is a drug-free way to apply gentle pressure and encourage dilation. Increasingly, hospitals pair a Foley catheter with low-dose misoprostol rather than using either method alone. A network meta-analysis that pooled data across many trials found that combining a single-balloon catheter with misoprostol was the most effective strategy for achieving vaginal delivery within 24 hours and for reducing the odds of cesarean delivery, ranking highest among all methods evaluated.9American Journal of Obstetrics and Gynecology. Overview and network meta-analysis of labor induction agents – Section: Results
A randomized trial confirmed this pattern at the individual-study level: women who received a Foley catheter plus oral misoprostol reached active labor in about 11 hours on average compared with about 16 hours for misoprostol alone. A greater proportion of women in the combined group delivered vaginally within 24 hours.10PubMed Central. Labor induction with combined low-dose oral misoprostol and Foley catheter vs oral misoprostol alone at term gestation—a randomized study – Section: Results Another trial found that the combination also reduced the total amount of misoprostol needed, lowering the chances of needing additional doses.11PubMed Central. Foley catheter plus misoprostol versus misoprostol alone for labor induction – Section: Results The logic is straightforward: the catheter works mechanically to stretch the cervix while the drug softens it chemically, and together they move things along faster than either one alone.
Tachysystole and Overstimulation
One of the main risks with any contraction-producing drug is tachysystole, defined as more than five contractions in a 10-minute window. When contractions come too fast, the uterus does not fully relax between them, and blood flow to the baby can temporarily drop. This sounds alarming, and it triggers close monitoring, but the clinical picture is more nuanced than the name implies.
A study that tracked outcomes in women who developed tachysystole during induction found that while non-reassuring fetal heart rate patterns were more common in the tachysystole group, actual newborn outcomes like Apgar scores and umbilical cord blood measures were similar between the two groups.12Gynecologic and Obstetric Investigation. Tachysystole Following Cervical Ripening and Induction of Labor Is Not Associated with Adverse Outcomes That does not mean tachysystole is harmless, but it does suggest that when it is recognized and managed promptly, outcomes tend to be fine.
When tachysystole occurs and the fetal heart tracing looks concerning, providers can stop the oxytocin drip, reposition you, give IV fluids, or administer a tocolytic drug to temporarily relax the uterus. A Cochrane review examined the use of tocolytic agents for this purpose and found that treatment probably reduced abnormal fetal heart tracings, though the evidence came from small trials.13PubMed Central. Acute tocolysis for uterine tachysystole or suspected fetal distress – Section: Main results With oxytocin, stopping the drip often resolves the problem within minutes because the drug clears the bloodstream quickly. With misoprostol, the drug cannot be “turned off” once absorbed, which is one reason providers watch the fetal monitor closely after each dose.
Induction After a Prior Cesarean
If you have had a previous cesarean delivery and are attempting a vaginal birth this time, the choice of induction drug takes on an extra dimension: uterine rupture. The scar from a prior cesarean is a structural weak point, and anything that increases the force or frequency of contractions increases the risk that the scar gives way.
A landmark study in the New England Journal of Medicine quantified these risks starkly. Among women with a prior cesarean, uterine rupture occurred at a rate of about 5 per 1,000 during spontaneous labor, about 8 per 1,000 when labor was induced without prostaglandins, and roughly 25 per 1,000 when prostaglandins were used for induction.14PubMed. Risk of uterine rupture during labor among women with a prior cesarean delivery – Section: RESULTS That last figure represents roughly a 15-fold increase over the baseline rupture rate in women who simply had a repeat cesarean without labor.
More recent data from a population-based cohort study found a similar pattern. Prostaglandin induction carried about 2.6 times the odds of uterine rupture compared with spontaneous labor onset, while mechanical induction using a catheter alone carried no significant excess risk.15Scientific Reports. Uterine rupture risk during trial of labor after one cesarean in a population-based cohort study of induction method and labor management – Section: Results This is why many institutions avoid prostaglandin use entirely in women with a uterine scar, favoring mechanical ripening with a Foley catheter followed by oxytocin if induction is needed.
Whether oxytocin itself adds significant rupture risk beyond spontaneous labor has been debated. One survival analysis found that after accounting for the length of labor and other confounding factors, the difference between induced and spontaneous labor was not statistically significant, though an unfavorable cervix at the start of induction was independently associated with higher rupture risk.16PubMed Central. Association of Induction of Labor and Uterine Rupture in Women attempting Vaginal Birth After Cesarean: A Survival Analysis – Section: Results The practical takeaway: if you have a prior cesarean and are a candidate for induction, expect your provider to avoid prostaglandins and to choose the method with the most controllable intensity.
Elective Induction at 39 Weeks
For years, the conventional wisdom was that labor should not be induced without a clear medical reason, because induction was assumed to raise the risk of cesarean delivery. The ARRIVE trial, published in 2018, challenged that thinking. This large trial enrolled low-risk first-time mothers and randomly assigned them to either induction at 39 weeks or expectant management, meaning waiting for labor to start on its own or for a medical reason to intervene.
The results were counterintuitive: cesarean delivery was actually less common in the induction group, about 19 percent versus 22 percent in the expectant-management group. The composite measure of adverse newborn outcomes was also numerically lower in the induction group, occurring in roughly 4 percent of babies versus 5 percent, though this difference did not quite reach conventional statistical significance.17PubMed Central. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women – Section: Results A secondary analysis found that in the broader population, induction at 39 weeks was associated with a reduced composite of adverse perinatal outcomes at about 4 percent versus 6 percent, with increasing body mass index being a factor that worsened outcomes regardless of group.18PubMed Central. Elective Labor Induction at 39 Weeks Compared With Expectant Management: Factors Associated With Adverse Outcomes in Low-Risk Nulliparous Women – Section: Results
The trial shifted practice at many hospitals, but it drew criticism too. An epidemiologic review noted that the trial’s comparison group was expectant management, not a “no induction” control, meaning some women in the waiting group ended up being induced later at 40 or 41 weeks anyway. The comparison, then, was really between induction at 39 weeks and induction or spontaneous labor somewhat later.19PubMed Central. The ARRIVE Trial: Interpretation from an Epidemiologic Perspective This matters when generalizing the results to real-world decisions, because the trial population was tightly selected and the care was standardized in ways that not every hospital replicates.
Pain and Epidural Timing
One aspect of pharmacological induction that often catches people off guard is how early the pain can ramp up. In spontaneous labor, contractions typically build gradually over hours, giving you time to adjust. Induced labor often produces stronger contractions sooner, especially with oxytocin, where the dose is deliberately escalated. A study comparing medically induced deliveries with spontaneous-onset labor found that first-time mothers receiving induction drugs reached the point of epidural placement earlier in the process. Multiparous women showed an even more dramatic gap, with epidural administration happening considerably sooner in induced labors.20European Journal of Midwifery. Medically induced labor: Epidural analgesia and women’s perceptions of pain in early labor – Section: RESULTS This does not mean that induced labor is necessarily more painful overall, but the pain trajectory is compressed, and it helps to plan your pain management preferences with that in mind.
Less Common Pharmacological Agents
Beyond the workhorses of oxytocin and prostaglandins, a few other drugs appear in specific clinical scenarios. Mifepristone is a progesterone antagonist best known for its role in medical abortion. Because progesterone is the hormone that keeps the uterus relaxed during pregnancy, blocking it can promote cervical ripening and increase the uterus’s sensitivity to prostaglandins. In a study of late intrauterine fetal death, pretreating with mifepristone before giving misoprostol cut the average induction-to-delivery time roughly in half compared with misoprostol alone, and the total misoprostol dose needed was significantly lower.21PubMed Central. Role of Combination OF Mifepristone and Misoprostol Verses Misoprostol alone in Induction of Labour in Late Intrauterin Fetal Death: A Prospective Study – Section: Results This combination is mostly used in cases of fetal death rather than in routine term inductions, though research into broader applications continues.
Nitric oxide donors like isosorbide mononitrate have been investigated for cervical ripening. These drugs relax smooth muscle, including the cervix, and a randomized trial found that vaginal isosorbide mononitrate improved cervical distensibility.22PubMed. Vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening at term: a randomized controlled study – Section: RESULTS The appeal of nitric oxide donors is that they ripen the cervix without triggering contractions, which could theoretically allow outpatient cervical preparation before a scheduled induction day. A Cochrane review confirmed this potential but noted that the evidence is not yet strong enough to recommend routine use.23PubMed Central. Nitric oxide donors for cervical ripening and induction of labour For now, these remain research tools rather than standard options at most hospitals.
Castor Oil and Folk Induction Methods
Castor oil is probably the most enduring home remedy for “getting labor started,” and unlike many folk methods, it has an identifiable pharmacological mechanism. When you swallow castor oil, your gut breaks it down into ricinoleic acid, which activates a specific prostaglandin receptor called EP3. That receptor sits on both intestinal and uterine smooth muscle cells, which is why castor oil produces diarrhea and uterine cramps at the same time.24PubMed Central. Castor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptors In mice lacking the EP3 receptor, castor oil produced neither effect, confirming that the pathway is real and specific.
Having a real mechanism, though, does not make castor oil a reliable or recommended induction method. The uterine contractions it produces are uncontrolled and often irregular, and the gastrointestinal side effects can leave you dehydrated and miserable heading into labor. No major obstetric guideline includes castor oil as a recommended option, and it is worth distinguishing between “can cause contractions” and “can safely and predictably induce labor.” The drugs used in hospitals exist precisely because their dose can be titrated, their effects monitored, and their administration stopped if something goes wrong.
Oxytocin Versus Prostaglandins in Specific Situations
If your water has already broken but contractions have not started, the choice between oxytocin and prostaglandins plays out a bit differently than in a standard induction with intact membranes. A randomized trial comparing the two in women with premature rupture of membranes at term found that oxytocin produced a notably faster trajectory: the average time from induction to active labor was about 5 hours with oxytocin versus roughly 9 hours with vaginal PGE2, and the overall induction-to-delivery interval was about 3.5 hours with oxytocin versus nearly 10 hours with PGE2. Cesarean delivery rates and newborn outcomes were similar between the groups.25PubMed. Randomized trial of vaginal prostaglandin E2 versus oxytocin for labor induction in term premature rupture of membranes – Section: RESULTS When membranes are already ruptured, the risk of infection rises with time, so the faster route to delivery with oxytocin is a meaningful advantage. This is one reason guidelines favor oxytocin as the first-line agent specifically in the setting of ruptured membranes with a favorable cervix.